Breast Cancer - Anti-inflammatory diets could help lower the risk of breast cancer
Can't see this email? View it online
   
  Breast Cancer  
  The latest breast cancer news from News Medical  
 Natural killer cells target breast cancer using the body’s immune systemNatural killer cells target breast cancer using the body’s immune system
 
In a recent study, researchers investigated how natural killer cells target breast cancer using the body's own immune system.
 
   Anti-inflammatory diets could help lower the risk of breast cancerAnti-inflammatory diets could help lower the risk of breast cancer
 
Women eating more foods that increase inflammation in the body have a 12% increase in their risk of breast cancer relative to women who did not.
 
   More informed choices of contraceptives can prevent breast cancerMore informed choices of contraceptives can prevent breast cancer
 
Hormonal contraceptives, e.g. the pill, the patch, and the vaginal ring, contain synthetic hormones that prevent pregnancy by either stopping ovulation, changing the cervical mucus to stop sperm from passing through the cervix and finding an egg, or changing the womb's lining to prevent a fertilized egg from being implanted in it.
 
 Mutations in HER2 gene can spur tumor growth in breast cancer
 
Mutations in HER2 gene can spur tumor growth in breast cancerMutations in a gene related to HER2, a gene frequently implicated in breast cancers and a variety of other malignancies, can amplify activity that spurs tumor growth, a new study led by UT Southwestern researchers suggests.
 
 
 Breast cancer survivors have higher risk of new cancer diagnosis compared to healthy individuals
 
Breast cancer survivors have higher risk of new cancer diagnosis compared to healthy individualsA new study finds breast cancer survivors in general have higher risk of new cancer diagnosis compared to healthy individuals. The article, which appears in CANCER, states that compared to the general population in the United States, the risk of new cancer diagnoses among survivors was 20% higher for those with hormone receptor (HR) positive cancers and 44% higher for those with HR-negative cancers.
 
 
 New treatment may improve outcomes for patients with BRCA mutation-associated early breast cancer
 
New treatment may improve outcomes for patients with BRCA mutation-associated early breast cancerResults were released this week on a new treatment with the potential to improve the outcomes for patients with hereditary BRCA mutations and high-risk, early-stage breast cancer.